NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will host a teleconference at 8:00 a.m. EDT (7:00 a.m. CDT) on Monday, June 6, 2011, to review data presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Company executives will provide an overview of data presented at the meeting on the oncology portfolio and address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at: http://investor.bms.com or by dialing 913-312-0677, confirmation code: 2538916. A replay of the call will be available beginning at 11:00 a.m. EDT on June 6 through midnight EDT on June 20. The replay can be accessed at http://investor.bms.com or by dialing 402-280-9013, confirmation code: 2538916.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
CONTACT:
Bristol-Myers Squibb Company
Media:
Jennifer Fron Mauer, 609-252-6579
[email protected]
or
Investors:
John Elicker, 609-252-4611
[email protected]
KEYWORDS: United States North America Illinois New York
INDUSTRY KEYWORDS: Health Biotechnology Clinical Trials Oncology Other Health
MEDIA:
| Logo |